Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: An infodemiological study

Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: An infodemiological study

Several clinical trials have demonstrated that many SGLT-2 inhibitors (SGLT2i) and GLP-1 receptor agonists (GLP-1 RA) can reduce the risk of cardiovascular events in patients with Type 2 diabetes and atherosclerotic cardiovascular disease. Recent reports indicate an underutilization of new cardiomet...

Full description

Bibliographic Details
Main Authors: Omar Dzaye, Philipp Berning, Alexander C. Razavi, Rishav Adhikari, Kunal Jha, Khurram Nasir, John W. Ayers, Martin Bødtker Mortensen, Michael J. Blaha
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
cardiometabolic medicine
SGLT 2 inhibitors
GLP-1 receptor agonist
Google trends
national prescription audit
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.936651/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.936651/full

Similar Items